, Tracking Stock Market Picks
Enter Symbol:
Rating: AFFX
Neutral $9

Affymetrix, Inc. (NASDAQ: AFFX) reiterated to Neutral with price target $9 by UBS

Thursday,  Feb 6, 2014  10:25 AM ET by Dave Ficere

UBS reiterated Affymetrix, Inc. (NASDAQ: AFFX) to Neutral with price target $9. Previously UBS rated Neutral
with price target $4 Affymetrix, Inc. (NASDAQ: AFFX) on 02/01/2013, when the stock price was $3.84. Since then, Affymetrix, Inc.'s stock price has gained 87% as of 02/06/2014's recent price of $7.17.

Affymetrix scientists invented the world's first high-density microarray and began selling the first commercial microarray. Since then, Affymetrix GeneChip technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. Affymetrix' patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyzing the relationship between genetics and health.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy